TNF and Hepatic steatosis: Among NAFLD populations, some trials have demonstrated that TRE improves body weight, body fat, inflammatory markers (such as hs-CRP and TNF-α), and liver-related assessments (including hepatic steatosis, liver fibrosis, and liver enzyme levels).